About Larry Frum

Posts by Larry Frum:

Moving for Melanoma of Delaware Supports Melanoma Research at Johns Hopkins

Moving for Melanoma of Delaware Supports Melanoma Research at Johns Hopkins

Members of the Johns Hopkins Melanoma Program participated in an annual 5K walk/run event and received funds raised by the event during a visit in February. The 5K event in Wilmington, Delaware, and sponsored by Moving for Melanoma of Delaware for the past 11 years raises money for melanoma research, community education and support patients and(...)

Pancreatic Cancer Matters: Right Treatment at the Right Time

Pancreatic Cancer Matters: Right Treatment at the Right Time

Our collaborative team of scientists, physicians and allied health workers at the Johns Hopkins Kimmel Cancer Center specialize in translating science learned in the laboratory into exceptional clinical care. The Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care is a world leader in the diagnosis and management of pancreatic cancer, leading all(...)

The Future of Pancreatic Cancer Treatments

The Future of Pancreatic Cancer Treatments

Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances in treatment headed? Elizabeth Jaffee, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, describes explains in a 2018 interview on WYPR. http://www.wypr.org/post/why-pancreatic-cancer-so-deadly

Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers

Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers

A guideline on guide the clinical practice of managing adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy continues to draw readers nearly a year after its publication. The document’s development, led by Julie Brahmer, M.D., co-director of the upper aerodigestive department in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and a professor of(...)

Jaffee looks to the future of checkpoint immunotherapy for cancer treatment

Jaffee looks to the future of checkpoint immunotherapy for cancer treatment

Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research(...)

Three Minutes with Oncologist Michael Carducci

Three Minutes with Oncologist Michael Carducci

Michael Carducci, M.D., is the associate cancer center director for clinical research within the Johns Hopkins Kimmel Cancer Center and the regional research director for the Greater Washington, D.C., area for the Kimmel Cancer Center. In his many years as an oncologist, Carducci has expertise in various types of cancer including bladder, kidney, prostate and(...)

Music Video Features Johns Hopkins Pediatric Oncology Patient to Raise Awareness


A collaboration between a Johns Hopkins pediatric patient, a rising indie alt/pop group and an organization dedicated to spreading the medicine of music created a new music video for an original song, “No Giving Up.” East of Eli, fronted by singer/songwriter/actor Nathan West and his wife and actress Chyler Leigh, joined musical forces with Grammy-winning(...)

Johns Hopkins Kimmel Cancer Center Immunotherapy Experts Named Bloomberg~Kimmel Professors


Three Johns Hopkins Kimmel Cancer Center researchers were recognized as the first Bloomberg~Kimmel professors in cancer immunology during a ceremony at Johns Hopkins. The event marked the beginning of the Bloomberg~Kimmel Professorships program, and the three scientists were recognized for their work in precision immunotherapy, the bacterial contributions in the microbiome, and how targeting the(...)

Researchers Advance Role of Circulating Tumor DNA to Detect Early Melanoma Growth, Uncover Treatment Options


Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer growth and spread but also uncover new treatment options that tumor genetic analysis alone may(...)